A Phase I Dose Escalation Study of CGM097 in Adult Patients With Selected Advanced Solid Tumors

Clinical trial NCT01760525 · COMPLETED

Trial details

NCT number: NCT01760525
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Solid Tumor With p53 Wild Type Status

Start date: 2013-03-20
Primary completion: 2020-07-24
Enrollment: 51

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.